Format

Send to

Choose Destination
Heart Lung. 2017 Mar - Apr;46(2):106-109. doi: 10.1016/j.hrtlng.2016.11.005. Epub 2017 Jan 4.

Extracorporeal Membrane Oxygenation in Massive Pulmonary Embolism.

Author information

1
Hackensack University Medical Center, Hackesack, NJ, USA; Rutgers New Jersey Medical School, Newark, NJ, USA.
2
Hackensack University Medical Center, Hackesack, NJ, USA; Valley Medical Group and Valley Hospital, Ridgewood, NJ, USA.
3
Hackensack University Medical Center, Hackesack, NJ, USA.
4
Hackensack University Medical Center, Hackesack, NJ, USA; Rutgers New Jersey Medical School, Newark, NJ, USA; Valley Medical Group and Valley Hospital, Ridgewood, NJ, USA. Electronic address: Narayan@westwoodcardio.com.

Abstract

BACKGROUND:

Extracorporeal Membrane Oxygenation (ECMO) has been suggested for cardiopulmonary support in patients with massive pulmonary embolism (PE) refractory to other treatment or as bridging to embolectomy. The survival benefit from ECMO in patients with massive PE remains unclear.

METHODS:

Here, we describe 5 cases in which ECMO was used as cardiopulmonary support following massive near-fatal pulmonary embolism.

RESULTS:

The overall mortality in patients with massive PE that received ECMO support was 40%. Death occurred secondary to ECMO-related complication in one case and due to inability to maintain adequate cerebral perfusion despite ECMO support in the second case.

CONCLUSIONS:

ECMO can be considered as a treatment modality for patients with massive PE.

KEYWORDS:

Cardiopulmonary support; Complication; Extracorporeal Membrane Oxygenation; Mortality; Pulmonary embolism

PMID:
28063605
DOI:
10.1016/j.hrtlng.2016.11.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center